During my PhD candidature at IMPACT, I have acquired a diverse set of skills that have allowed me to make significant contributions to mental health research. Specifically, my research investigates the impact of lung inflammation on mental health with the ultimate goal of identifying novel targets for tailored treatments for lung-related mental health disorders.
As an honours student, I was offered the opportunity to work with the TRIALS team. I worked on two projects, the N-Acetyl Cysteine (NAC) as a pharmacotherapy for methamphetamine (‘ice’) dependence (N-ICE trial) and NAC for Unipolar Depression (UD-NAC) trial. My experience working with the TRIALS team on these projects has enriched my learning experience by introducing me to skills and techniques I otherwise would not have encountered within my own project. These opportunities helped me to gain valuable skills that I have carried with me into my PhD. The TRIALS team were welcoming and supportive, I received an invaluable introduction to the processes of clinical trial research.
Find A Supervisor
Researchers at IMPACT TRIALS bring world-class expertise to mental and physical illnesses that are impacting our communities today. Our focus is on undertaking research that both informs interventions in clinical practice and identify factors that will enhance personalised medicine in psychiatry.
At TRIALS we have a portfolio of work that encompasses exploration of novel psychiatric therapies, investigation of biomarkers that underline prevalent mental and physical health conditions, establishing lifestyle and online psychological interventions and drug safety.
If you are a postgraduate student interested in collaborating on a project, securing funding, or gaining information about publications, find a researcher at TRIALS that closely aligns with your area of interest.
Please contact the TRIALS team to discuss post-doctoral opportunities.
- Information on the annual Alfred Deakin Postdoctoral Research Fellowship round.
- How can IL-6 be used to better predict treatment response in affective disorders?
- Exploring qualitative outcomes in a study of adjunctive mangosteen pericarp for schizophrenia.
- Exploring duration of illness as a factor in symptom change in RCTs
- Can N-acetyl cysteine be effective as a monotherapy in psychiatry?
- Personality disorder and treatment response in people who are dependent on methamphetamine
- Examining the influence of systemic comorbidity on inflammation and treatment response in depression
- Examining the relationship between symptoms of anxiety and markers of inflammation in depression.
Download our annual report.